|
|
|
|||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||
TB Notes NewsletterReturn to Main Menu - TB Notes 2, 2007No. 2, 2007NEW CDC PUBLICATIONSAndre M, Ijaz K, Tillinghast JD, Krebs VE, Diem LA, Metchock B, Crisp T, and McElroy PD. Transmission network analysis to complement routine tuberculosis contact investigations. Am J Public Health 2007;97: 470-477. Baumann MH, Nolan R, Petrini M, Lee YCG, Light RW, and Schneider E. Pleural tuberculosis in the United States: incidence and drug resistance. (PDF) Chest Apr 2007: 1125–1132. CDC. Extensively drug-resistant tuberculosis. MMWR 2007; 56(11): 250-253. CDC. Trends in tuberculosis incidence. MMWR 2007; 56(11): 245-250. CDC. World TB Day – March 24, 2007 [box]. MMWR 2007; 56(11): 245. CDC/DTBE. Extensively Drug-Resistant Tuberculosis (XDR TB) - Fact sheet 2007. CDC/DTBE. CDC’s Role in Preventing Extensively Drug-Resistant Tuberculosis (XDR TB) - Fact sheet 2007. CDC/DTBE. Forging Partnerships to Eliminate Tuberculosis, 2007 - Guide and toolkit. CDC/DTBE. Multidrug-Resistant Tuberculosis (MDR TB) - Fact sheet 2007. CDC/DTBE. The Revised Report of Verified Case of Tuberculosis. - Fact sheet 2007. Castro KG. Tuberculosis surveillance: data for decision-making [editorial]. Clinical Infectious Diseases 2007 May 15; 44: 1268-70. Cheruvu M, Plikaytis BB, Shinnick TM. The acid-induced operon Rv3083–Rv3089 is required for growth of Mycobacterium tuberculosis in macrophages. Tuberculosis 2007; 87: 12-20. Dewan PK, Grinsdale J, Kawamura LK. Low sensitivity of a whole-blood interferon-gamma release assay for detection of active tuberculosis. Clinical Infectious Diseases 2007 Jan 1; 44: 69-73. Frieden TR, Munsiff SS, Desai Ahuja S. Outcomes of multidrug-resistant tuberculosis treatment in HIV-positive patients in New York City, 1990-1997 [letter]. International Journal of Tuberculosis and Lung Disease January 2007; 11 (1): 116. Fu LM, Shinnick TM. Understanding the action of INH on a highly INH-resistant Mycobacterium tuberculosis strain using Genechips. Tuberculosis 2007; 87:63-70. Haddad MB, Diem LA, Cowan LS, Cave MD, Bettridge J, Yun L, Winkler CS, Ingman DD, Oemig TV, Lynch A, Montero JT, McCombs SB, Ijaz K. Tuberculosis genotyping in six low-incidence states, 2000–2003. Am J Prev Med 2007; 32(3): 239–243. Ijaz K, McElroy PD, Jereb J, Navin TR, Castro KG. Safety of the rifampin and pyrazinamide short-course regimen for treating latent tuberculosis infection [letter]. Clinical Infectious Diseases 2007 Feb 1; 44(3):464-5. Jiehui L, Marks SM, Driver CR, Diaz FA, Castro AF, de Regner AF, Gibson AE, Dokubo-Okereke K, Munsiff SS, TB Epidemiologic Studies Consortium. Human immunodeficiency virus counseling, testing, and referral of close contacts to patients with pulmonary TB: feasibility and costs. J Public Health Management Practice 2007; 13(3): 252-62. Katz D, Albalak R, Wing JS, Combs V, for the Tuberculosis Epidemiologic Studies Consortium. Setting the agenda: A new model for collaborative tuberculosis epidemiologic research. Tuberculosis 2007; 87: 1-6. Riekstina V, Leimane V, Holtz TH, Leimans J, Wells CD. Treatment outcome cohort analysis in an integrated DOTS and DOTS-Plus TB program in Latvia. International Journal of Tuberculosis and Lung Disease May 2007; 11(5): 585-587. Sable SB. Plikaytis BB. Shinnick TM. Tuberculosis subunit vaccine development: impact of physicochemical properties of mycobacterial test antigens. Vaccine Feb 19; 25(9):1553-66. Thoen CO and LoBue PA. Mycobacterium bovis tuberculosis: forgotten, but not gone [comment]. The Lancet 2007 April 14; 369 (9569): 1236-1237. Walton W. New activities and resources for engaging all health care providers in TB elimination [editorial]. International Journal of Tuberculosis and Lung Disease March 2007; 11 (3): 246.
Last Reviewed: 05/18/2008 |
|
|
If you would like to order any of the DTBE publications please visit the online order form. You will need Adobe Acrobat™ Reader v5.0 or higher to read pages that are in PDF format. Download the Adobe Acrobat™ Reader. If you have difficulty accessing any material on the DTBE Web site because of a disability, please contact us in writing or via telephone and we will work with you to make the information available. Division of Tuberculosis Elimination
Centers for Disease Control & Prevention |